BRIEF published on 03/02/2026 at 15:53, 1 day 1 hour ago JP Morgan's investment in DBV Technologies reaches new thresholds Crossing Thresholds Equity Swaps Shares And Voting Rights DBV Technologies JP Morgan
BRIEF published on 02/28/2026 at 20:30, 2 days 20 hours ago DBV Technologies reveals promising new results for VIASKIN Peanut Clinical Study Immunotherapy DBV Technologies Food Allergies Viaskin Peanut
BRIEF published on 02/28/2026 at 20:30, 2 days 20 hours ago DBV Technologies Unveils Promising Phase 3 VITESSE Study Results at AAAAI 2026 DBV Technologies Phase 3 Results Viaskin Peanut Patch Peanut Allergy Treatment VITESSE Study
PRESS RELEASE published on 02/28/2026 at 20:25, 2 days 20 hours ago DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting DBV Technologies presents successful Phase 3 VITESSE study data at AAAAI Annual Meeting, highlighting VIASKIN Peanut Patch efficacy in treating peanut-allergic children DBV Technologies Food Allergies Viaskin Peanut Patch Phase 3 VITESSE Study AAAAI Annual Meeting
BRIEF published on 02/09/2026 at 22:35, 21 days 18 hours ago DBV Technologies to Join Guggenheim Biotech Summit Biopharmaceutical DBV Technologies Food Allergies VIASKIN® Patch Guggenheim Securities Summit
BRIEF published on 02/09/2026 at 22:35, 21 days 18 hours ago DBV Technologies at the Emerging Outlook: Biotech Summit conference Immunotherapy DBV Technologies Viaskin Food Allergies Biotech Summit
PRESS RELEASE published on 02/09/2026 at 22:30, 21 days 18 hours ago DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit DBV Technologies to participate in Guggenheim Securities Biotech Summit with CEO Daniel Tassé presenting at the fireside chat on February 12, 2026. Company focusing on food allergy treatment Guggenheim Securities DBV Technologies Food Allergies VIASKIN Patch Biotech Summit
BRIEF published on 02/06/2026 at 09:59, 25 days 7 hours ago Janus Henderson crosses 5% threshold in DBV Technologies Euronext Paris Actions Janus Henderson Threshold Crossing DBV Technologies
BRIEF published on 02/03/2026 at 14:04, 1 month ago JP Morgan reaches new thresholds at DBV Technologies Crossing Thresholds Shares And Voting Rights DBV Technologies JP Morgan Equity Swap Contract
BRIEF published on 01/20/2026 at 11:41, 1 month 14 days ago Thresholds crossed at DBV Technologies by JP Morgan Chase & Co. Shares And Voting Rights DBV Technologies Financial Contracts JP Morgan Participation Thresholds
Published on 03/03/2026 at 15:00, 2 hours ago Jaguar Health Secures an Additional $3 Million Payment from Future Pak for Mytesi and Canalevia-CA1
Published on 03/03/2026 at 14:50, 2 hours 10 minutes ago Kingfisher Announces Closing of C$30 Million Bought Deal Offering
Published on 03/03/2026 at 14:30, 2 hours 30 minutes ago Unusual Machines to Participate in Two March Investor Conferences
Published on 03/03/2026 at 14:30, 2 hours 30 minutes ago Ameriwest Critical Metals Engages APEX Geoscience Ltd. to Advance Its Bornite Project
Published on 03/03/2026 at 16:25, 34 minutes ago Huawei Releases 115 Industrial Intelligence Showcases with Global Customers; and Launches 22 Industrial Intelligence Solutions with Partners at MWC 2026
Published on 03/03/2026 at 15:55, 1 hour 4 minutes ago Huawei's Yang Chaobin: Creating Mobile Value Creates a Better Intelligent World
Published on 03/03/2026 at 15:15, 1 hour 44 minutes ago Omio Group breaks boundaries, accelerating product innovation and market expansion across all business units in 2026
Published on 03/03/2026 at 15:15, 1 hour 44 minutes ago Beyond Telcos: Exploring Deterministic Paths to Business Success in the Agentic Era
Published on 03/03/2026 at 09:57, 7 hours 3 minutes ago Disclosure of shares outstanding and voting rights - 03.03.2026
Published on 03/03/2026 at 07:00, 10 hours ago Thales reports its 2025 full-year results - press release - 3rd March 2026
Published on 03/02/2026 at 17:35, 23 hours 25 minutes ago Disclosure of transactions in own shares from February 23 to February 27, 2026